- by esalazar@marketresearch.com
- January 14 2016
- genetic testing
- proteomics
- cancer diagnostics
- veterinary diagnostics
- microarrays
- flow cytometry
- prenatal
- translational research
Affymetrix Acquisition Deepens and Complements Thermo Fisher’s Existing Product Groups in Clinical Molecular Testing, Translational Research, Flow Cytometry and Applied Testing
Kalorama Information offers additional analysis of the markets discussed below with an upcoming title on clinical and research microarrays as well as published reports including The Market for Prenatal, Newborn and Carrier Genetic Testing , The World Market for Cancer Diagnostics, 6 th Ed. , Proteomics Research Markets , The World Market for Flow Cytometry in IVD Applications , and The World Market for Veterinary Diagnostics.
Thermo Fisher Scientific’s reach in the global life sciences market ...
- by esalazar@marketresearch.com
- November 18 2015
- proteomics
- alzheimer’s disease
- biomarkers
Search for Biomarkers Crucial to Neurodegenerative Disease Therapeutics and Diagnostics
Kalorama Information offers related market research titles with Proteomics Markets (research and clinical markets ), Proteomics Research Markets and The Global Market for Biomarkers.
The debilitating neurodegenerative diseases Alzheimer’s and Parkinson’s have vexed healthcare in terms of both therapy and definitive antemortem diagnosis. The localized nature of the diseases in the central nervous system (CNS) makes the development of in vitro diagnostic (IVD) tests difficult. An incomplete unde...
- by esalazar@marketresearch.com
- May 1 2015
- proteomics
- mass spectrometry
The New Workhorses in Proteomics Research - Q-TOFs and Orbitraps
Changes in the competitive and technological landscape of proteomics research can take a long time to take hold. Core instruments in translational research for biomarkers and drug targets, such as mass spectrometers (MS), may be replaced or upgraded in a laboratory only once every ten to fifteen years. Many proteomics core labs at universities and research centers still rely on manufacturer-discontinued MS systems, though reinforcements in the lab have been conspicuous in recent years. New MS te...
- by esalazar@marketresearch.com
- April 3 2015
- proteomics
- electrophoresis
- biotechnology
Will Capillary Electrophoresis Move to the Front of the Line in Top-Down Proteomics?
This blog post covers market trends in proteomics research - a field recently profiled by Kalorama Information with Proteomics Research Markets: Instruments (Mass Spectrometry, Liquid Chromatography, Electrophoresis), Disease Areas (Oncology, Cardio/Blood, Neurology, Other) Market Share and Trends. The report offers unique insight into a mass spectrometry- and analytical separation-centric life sciences market, including market shares by geography, instrument type, and vendor.
The steadily evo...
- by esalazar@marketresearch.com
- February 20 2015
- mass spectrometry
- proteomics
Mass Spec Imaging Develops Tissue Samples as Resource for Proteomic Biomarker Discovery
This blog post covers market trends in proteomics research - a field recently profiled by Kalorama Information with Proteomics Research Markets: Instruments (Mass Spectrometry, Liquid Chromatography, Electrophoresis), Disease Areas (Oncology, Cardio/Blood, Neurology, Other) Market Share and Trends. The report offers unique insight into a mass spectrometry- and analytical separation-centric life sciences market, including market shares by geography, instrument type, and vendor.
Mass spectrometr...
- by esalazar@marketresearch.com
- February 6 2015
- alzheimer’s disease
- companion diagnostics
- proteomics
Alzheimer’s Disease Assays Target Clinical Trial Markets First
Outside of the $50+ billion clinical in vitro diagnostics (IVD) market , analytical instruments and lab diagnostics find major applications in the discovery of clinically significant biomarkers, therapeutics development, and other life sciences research activities. Entire classes of assays are originally developed to validate biomarkers as surrogate endpoints for disease, or as mechanism targets for drug development. The potential of pre-clinical assay markets is not lost to Amarantus BioScience...
- by bcarlson@marketresearch.com
- September 23 2014
- proteomics
In Proteomics Market, Desire For New Therapies Meets Reality of Research Spending
There’s a lot of interest in identification and validation of novel biomarkers that may represent potential drug targets or may lead to novel diagnostic tests As detailed in our complete study of the proteomics market, researchers are looking to proteomics for these discoveries. Proteomics is the study of proteins, including the study of the structure and function of proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles...
